
Aspen sees Mounjaro sales topping 124 million in 2027
Aspen Pharmacare forecasts African sales of Eli Lillys Mounjaro will exceed 124 million dollars in the current financial year. The projection comes as demand surges in South Africa with upcoming launches planned in Nigeria and Kenya.
Xurve View
Insights:
Xurve View

ASPEN PHARMACARE HOLDINGS LT expects African sales of ELI LILLY & CO's Mounjaro to exceed $124M in the 2027 financial year, driven by surging demand across South Africa. The expansion relies on planned regulatory approvals and commercial launches in Nigeria and Kenya during the current fiscal period.








